Piyush Goyal addressed the Global Ambassador Meet on the Pharmaceutical Sector and the Curtain Raiser Ceremony of the Global Drug Regulators Conclave and International Exhibition of Pharma and Healthcare in New Delhi.
The Union Commerce and Industry Minister shared positive projections for the sector. He said India’s pharmaceutical industry is projected to double in size over the next five years. This growth will come from innovation, global partnerships, and expanding global market access.
Piyush Goyal noted key policy steps that support this outlook. He pointed out that India has signed nine Free Trade Agreements in recent years. Trade agreements now cover more than 50 countries. These deals provide preferential access to major global markets for Indian pharmaceutical products.The event brought together global ambassadors, regulators, and industry leaders. It served as a curtain raiser for the upcoming Global Drug Regulators Conclave and International Exhibition of Pharma and Healthcare. The gatherings aim to strengthen India’s position in the global pharmaceutical landscape.
Piyush Goyal stressed the importance of continued innovation and partnerships. He highlighted how improved market access through trade agreements will help Indian companies reach more customers worldwide. The minister’s remarks underline the government’s focus on making the pharma sector a stronger pillar of India’s economy.
The pharmaceutical industry plays a vital role in India’s exports and public health. With these new trade agreements in place, companies can expect smoother entry into key markets. This development comes as India continues to build its reputation as a reliable supplier of quality medicines globally.Piyush Goyal’s address is expected to boost confidence among industry players and international partners. Stakeholders will look forward to more details on how the projected doubling of industry size will be achieved in practical terms over the coming years.
Public and industry impact includes better export opportunities and stronger global ties. Companies in the pharmaceutical sector should explore the benefits offered by the nine new Free Trade Agreements. Businesses can expect improved market access in over 50 countries covered by these deals.The government continues to support growth in this sector through policy measures and international engagement. People working in pharma and healthcare can anticipate new partnership opportunities and expanded markets in the near future.
